Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CKD-351
DRUG
2 trials
Sponsors
Chong Kun Dang Pharmaceutical
Conditions
Ocular Hypertension
Primary Open Angle Glaucoma
Primary Open-angle Glaucoma
Phase 2
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
NCT04448223
Chong Kun Dang Pharmaceutical
Ocular Hypertension, Primary Open Angle Glaucoma
Start: 2020-06-11
End: 2022-12-05
Target: 100
Updated: 2020-06-25
Phase 3
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
NCT03762369
Chong Kun Dang Pharmaceutical
Ocular Hypertension, Primary Open-angle Glaucoma
Start: 2018-12-07
End: 2022-05-30
Target: 384
Updated: 2018-12-03